BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220706
DTEND;VALUE=DATE:20220708
DTSTAMP:20260516T024009
CREATED:20220126T093554Z
LAST-MODIFIED:20220303T093817Z
UID:32980-1657065600-1657238399@www.pharmajournalist.com
SUMMARY:Microbiome Connect: Europe
DESCRIPTION:The 8th Annual Microbiome Connect: Europe 2022 dedicated to showcasing the leading drug development and consumer product platforms applying live microbial consortia\, engineered microbes\, and microbial-derived metabolites for therapeutic and health applications in patients and consumers. \nAs the first EMA approved microbiome-targeted therapeutics emerge on the horizon\, drug developers will have to opportunity to benchmark their rational drug platforms\, targeting validated pathways in gastrointestinal\, neurological\, metabolic disorders\, as well as oncology-based indications. \nFurthermore\, there will be separate tracks dedicated to developing novel\, clinical-validated product formulations for nutritional\, digestive wellness\, oral and skincare applications. \nJoin the microbiome field to hear from biotechs\, pharma voices\, investment bodies\, consumer product brands and more\, on how to develop robust\, scalable\, and reproducible formulations for microbe-derived/-targeting products entering late-stage investigations and reaching for the market. \nTo know more visit: https://hubs.ly/Q012R7H40
URL:https://www.pharmajournalist.com/event/microbiome-connect-europe/
LOCATION:Amsterdam
ORGANIZER;CN="Kisaco Research":MAILTO:Jessica.Mockler@kisacoresearch.com
END:VEVENT
END:VCALENDAR